结核病诊断的临床研究与开发：从各自为政到协同合作。
Clinical research and development of tuberculosis diagnostics: moving from silos to synergy.
机构信息
Division of Pulmonary and Critical Care Medicine, Department of Medicine at San Francisco General Hospital and Curry International Tuberculosis Center, University of California, San Francisco, CA 94110, USA.
出版信息
J Infect Dis. 2012 May 15;205 Suppl 2(Suppl 2):S159-68. doi: 10.1093/infdis/jis194. Epub 2012 Apr 3.
Abstract
The development, evaluation, and implementation of new and improved diagnostics have been identified as critical needs by human immunodeficiency virus (HIV) and tuberculosis researchers and clinicians alike. These needs exist in international and domestic settings and in adult and pediatric populations. Experts in tuberculosis and HIV care, researchers, healthcare providers, public health experts, and industry representatives, as well as representatives of pertinent US federal agencies (Centers for Disease Control and Prevention, Food and Drug Administration, National Institutes of Health, United States Agency for International Development) assembled at a workshop proposed by the Diagnostics Working Group of the Federal Tuberculosis Taskforce to review the state of tuberculosis diagnostics development in adult and pediatric populations.
摘要
新的和改进的诊断方法的开发、评估和实施已经被人类免疫缺陷病毒 (HIV) 和结核病研究人员和临床医生一致认为是关键需求。这些需求存在于国际和国内环境中，以及成人和儿科人群中。结核病和 HIV 护理专家、研究人员、医疗保健提供者、公共卫生专家和行业代表，以及美国相关联邦机构（疾病控制和预防中心、食品和药物管理局、美国国立卫生研究院、美国国际开发署）的代表聚集在联邦结核病工作组诊断工作组成员提出的一个研讨会上，审查成人和儿科人群中结核病诊断方法的发展现状。
相似文献
1
Clinical research and development of tuberculosis diagnostics: moving from silos to synergy.
J Infect Dis. 2012 May 15;205 Suppl 2(Suppl 2):S159-68. doi: 10.1093/infdis/jis194. Epub 2012 Apr 3.
2
Implementation of HIV and Tuberculosis Diagnostics: The Importance of Context.
Clin Infect Dis. 2015 Oct 15;61Suppl 3(Suppl 3):S119-25. doi: 10.1093/cid/civ552.
3
Challenges in evaluating the cost-effectiveness of new diagnostic tests for HIV-associated tuberculosis.
Clin Infect Dis. 2013 Oct;57(7):1021-6. doi: 10.1093/cid/cit412. Epub 2013 Jun 20.
4
Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis.
J Infect Dis. 2012 May 15;205 Suppl 2(Suppl 2):S169-80. doi: 10.1093/infdis/jis044. Epub 2012 Mar 29.
6
Evaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact.
J Infect Dis. 2011 Nov 15;204 Suppl 4(Suppl 4):S1187-95. doi: 10.1093/infdis/jir412.
7
Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling.
Int J Tuberc Lung Dis. 2014 Sep;18(9):1012-8. doi: 10.5588/ijtld.13.0851.
8
Which new diagnostics for tuberculosis, and when?
J Infect Dis. 2012 May 15;205 Suppl 2:S191-8. doi: 10.1093/infdis/jis188. Epub 2012 Apr 3.
9
Promise versus reality: optimism bias in package inserts for tuberculosis diagnostics.
J Clin Microbiol. 2012 Jul;50(7):2455-61. doi: 10.1128/JCM.00842-12. Epub 2012 May 9.
10
New international efforts in childhood tuberculosis: proceedings from the 2002 Workshop on Childhood Tuberculosis, Montreal, Canada, 6-7 October 2002.
Int J Tuberc Lung Dis. 2004 May;8(5):630-5.
引用本文的文献
1
Performance of the low-cost phenotypic thin-layer agar MDR/XDR-TB Colour Test (first generation, 1G, Color Plate Test) for identifying drug-resistant Mycobacterium tuberculosis isolates in a resource-limited setting.
Res Sq. 2025 Jun 27:rs.3.rs-6697928. doi: 10.21203/rs.3.rs-6697928/v1.
2
Tuberculosis-loop-mediated isothermal amplification implementation in Cameroon: Challenges, lessons learned and recommendations.
Afr J Lab Med. 2022 Aug 26;11(1):1792. doi: 10.4102/ajlm.v11i1.1792. eCollection 2022.
3
Biomarkers That Correlate with Active Pulmonary Tuberculosis Treatment Response: a Systematic Review and Meta-analysis.
J Clin Microbiol. 2022 Feb 16;60(2):e0185921. doi: 10.1128/JCM.01859-21. Epub 2021 Dec 15.
4
Sputum Microscopy With Fluorescein Diacetate Predicts Tuberculosis Infectiousness.
J Infect Dis. 2017 Sep 1;216(5):514-524. doi: 10.1093/infdis/jix229.
5
Diagnostic Accuracy of Xpert Test in Tuberculosis Detection: A Systematic Review and Meta-analysis.
J Glob Infect Dis. 2016 Jan-Mar;8(1):32-40. doi: 10.4103/0974-777X.176143.
6
Prevalence of national treatment algorithm defined smear positive pulmonary tuberculosis in HIV positive patients in Brazzaville, Republic of Congo.
BMC Res Notes. 2014 Aug 28;7:578. doi: 10.1186/1756-0500-7-578.
7
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Cochrane Database Syst Rev. 2014 Jan 21;2014(1):CD009593. doi: 10.1002/14651858.CD009593.pub3.
8
Clinical application of volatile organic compound analysis for detecting infectious diseases.
Clin Microbiol Rev. 2013 Jul;26(3):462-75. doi: 10.1128/CMR.00020-13.
9
Immunogenicity of mycobacterial vesicles in humans: identification of a new tuberculosis antibody biomarker.
Tuberculosis (Edinb). 2013 Jul;93(4):448-55. doi: 10.1016/j.tube.2013.03.001. Epub 2013 Apr 2.
10
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Cochrane Database Syst Rev. 2013 Jan 31(1):CD009593. doi: 10.1002/14651858.CD009593.pub2.
本文引用的文献
1
Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis.
Int J Tuberc Lung Dis. 2012 Feb;16(2):203-5. doi: 10.5588/ijtld.11.0445.
2
Performance of the MGIT TBc identification test and meta-analysis of MPT64 assays for identification of the Mycobacterium tuberculosis complex in liquid culture.
J Clin Microbiol. 2011 Dec;49(12):4343-6. doi: 10.1128/JCM.05995-11. Epub 2011 Oct 12.
3
Microcolony culture techniques for tuberculosis diagnosis: a systematic review.
Int J Tuberc Lung Dis. 2012 Jan;16(1):16-23, i-iii. doi: 10.5588/ijtld.10.0065. Epub 2011 Oct 6.
4
Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis.
J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):219-23. doi: 10.1097/QAI.0b013e31822b75d4.
5
CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.
Am J Respir Crit Care Med. 2011 Oct 15;184(8):972-9. doi: 10.1164/rccm.201105-0827WS.
6
Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis.
Eur Respir J. 2011 Dec;38(6):1398-405. doi: 10.1183/09031936.00025711. Epub 2011 Jun 23.
7
New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Clin Chem Lab Med. 2011 Oct;49(10):1727-33. doi: 10.1515/CCLM.2011.634. Epub 2011 Jun 14.
8
Use of urine volatile organic compounds to discriminate tuberculosis patients from healthy subjects.
Anal Chem. 2011 Jul 15;83(14):5526-34. doi: 10.1021/ac200265g. Epub 2011 Jun 21.
9
Recent advances in the laboratory detection of Mycobacterium tuberculosis complex and drug resistance.
Clin Infect Dis. 2011 Jun;52(11):1350-5. doi: 10.1093/cid/cir146.
10
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.
Lancet. 2011 Apr 30;377(9776):1495-505. doi: 10.1016/S0140-6736(11)60438-8. Epub 2011 Apr 18.
Zotero 插件